Leila Turner-Scott and Angus Scott filed a lawsuit against the company, alleging that it designed and distributed a "defective product" that led to the death of their son Sam Nelson from an accidental overdose. Specifically, they're alleging that Sam died following the "exact medical advice GPT-4o had provided and approved."
Musk's lawyers used cross-examination to attack Altman's credibility, citing testimony from former OpenAI figures including Mira Murati, Ilya Sutskever and Helen Toner, along with older criticism from his career as a tech executive and investor. Musk's lawyers also highlighted OpenAI's dealings with companies in which Altman holds a financial stake, including Stripe, Cerebras and Helion.
Musk's attorney, Steven Molo, opened his cross-examination of Altman with the blunt question: "Are you completely trustworthy?" "I believe so," Altman told the federal California jury in the civil trial of Musk's lawsuit against Altman and OpenAI. "You don't know whether you're completely trustworthy?" Molo followed up, forcing Altman to respond, "I'll just amend my answer to yes." Molo then peppered Altman with questions about whether the billionaire chief executive tells the truth, lies to advance his business interests, or misleads the people he works with.
Bylaws adopted by OpenAI in October 2025 allow the CEO to remain at the helm so long as he or she has at least one-third support from the for-profit entity's board, according to an analysis of the bylaws by Musk's expert witness conducted in November 2025, the documents said. "Under the new Bylaws, a supermajority of the PBC's nonemployee directors is now needed to fire the CEO," said an excerpt of the analysis by Columbia law professor David M. Schizer, who took the witness stand last week.
Ming-Chi Kuo reported that OpenAI's smartphone is now expected to enter mass production in the first half of 2027, accelerated due to the growing AI phone market and a potential year-end IPO.